Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in ...
Jun 16, 2023
0
9
In a review article published in The Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MGH's Department of Radiation Oncology, and co-authors describe the evolution of proton therapy ...
Jun 8, 2023
0
10
The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement today regarding the PROSPECT clinical trial for patients with rectal cancer:
Jun 7, 2023
0
29
A team led by the National Cancer Centre Singapore (NCCS) with members from Singapore General Hospital, A*STAR's Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS), National University ...
Jun 7, 2023
0
6
Among patients with extensive stage small-cell lung cancer (SCLC) that is positive for expression of the Schlafen-11 gene (SLFN11), those who received maintenance atezolizumab immunotherapy plus the PARP inhibitor talazoparib ...
Jun 5, 2023
0
2
An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.
Jun 5, 2023
0
76
A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.
Jun 5, 2023
0
91
The Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, classify objective tumor response into one of four categories (complete or partial response, ...
Jun 3, 2023
0
4
Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of the liver, as well as cancers of the gallbladder, and are highly likely ...
Jun 2, 2023
0
26
Chemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer—the ...
Jun 1, 2023
0
2
